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Abstract
Introduction Previous studies have shown that most people
prefer to die at their own home. We investigated whether
physicians or bereaved relatives in retrospect differently
appreciate the dying of patients in an institution or at home.
Materials and methods Of 128 patients with incurable
cancer who were followed in the last phase of their lives,
103 passed away during follow-up. After death, physicians
filled out a written questionnaire for 102 of these patients,
and 63 bereaved relatives were personally interviewed.
Results Of 103 patients, 49 died in an institution (mostly a
hospital), and 54 died at home (or in two cases in a home-
like situation). Patients who had been living with a partner
relatively often died at home. Bereaved relatives knew of
the patient’s wish to die at home in 25 out of 63 cases; 20
of these patients actually died at home. Thirty-one patients
had no known preference concerning their place of dying.
Most symptoms and the care provided to address them were
equally prevalent in patients dying in an institution and
patients dying at home. Bereaved relatives were in general
quite satisfied about the provision of medical and nursing
care in both settings.
Conclusion We conclude that most patients’ preferences
concerning the place of dying can be met. In about half of
all cases, patients do not seem to have a clear preference
concerning their place of dying, which is apparently not a
major concern for many people. We found no indication
that dying in an institution or at home involves major
differences in the process and quality of dying.
Keywords End-of-life care . Place of death .
Cancer patients . Quality of dying
Introduction
The two most important events in life, that is, birth and
death, relatively often occur at home in The Netherlands.
Over the period 1995–2000, around one third of all Dutch
births were home deliveries [1]. Further, in 2001, about
40% of all deaths have been found to occur at home, 40%
in hospital, and about 20% in nursing homes [2]. Medical
care in The Netherlands is strongly founded on home-based
general practice. General practitioners or family physicians
provide all basic medical care to outpatients and serve as a
gate door to specialized care for patients with more
complex health problems.
In 2003, around 45% of deaths due to cancer occurred at
home in The Netherlands [3]. In the UK, the percentage of
cancer deaths at home is lower and falling, from 27% in
1994 to 22% in 2003 [4]. In a study of the place of death of
cancer patients in the Houston area, USA, 35% died at
home [5]. End-of-life care is thus, especially in The
Netherlands, rather often provided in the home situation
by general practitioners, home-care nurses, and informal
caregivers. Research has shown that dying at home is
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usually preferred over dying in an institution, in The
Netherlands as well as in other countries [6]. Such a
preference seems to be predominantly shaped by whether or
not people have sufficient informal carer resources [7]. In
contrast, people who are concerned about the medical
management of their symptoms may appreciate the easy
access to professional caregivers in an institutional setting.
Concerns about burdening relatives have also been found to
contribute to a wish to die in an institution [7]. The finding
that people’s wish to die at home becomes less predominant
when death is nearing may be related to such concerns, as
heavily burdening relatives with care duties is one of the
most commonly recognized threats to a peaceful dying
process [6]. A gradual shift in preference may also be due
to the growing awareness of seriously ill people that dying
sometimes involves problems and symptoms that are best
treated by professional caregivers in an institutional setting.
Finally, differential experiences of services also influence
people’s preferences [7].
Enabling people to make genuine choices about their
end-of-life care and to die at the place they prefer is often
seen as a major challenge to current end-of-life care [8–10].
Home-care patients have been reported to have more
control over the effects of their illness, medical care, and
treatment received than patients receiving institutional care
[11]. However, it is unclear if the relatively high home
death rate in The Netherlands is really beneficial to the
quality of death and dying. Little is known about the
experiences of dying patients and their caregivers in
different health care settings. We investigated to what
extent dying in an institution or at home involves differ-
ences in care and its appreciation by physicians and
bereaved relatives.
Materials and methods
Patients
This study concerns a sub-sample of a cohort of 128
patients with advanced breast cancer, colorectal cancer,
ovary cancer, lung cancer, or prostate cancer, who were
followed for a study on end-of-life care needs and practices
during the last stage of their lives [12]. Of these patients,
103 died within the time frame during which we were able
to approach attending clinical specialists, general practi-
tioners, and bereaved relatives for an after-death data
collection. In 102 cases, physicians were willing to fill out
a written questionnaire on the medical treatment and dying
process of these patients: Questionnaires were filled out by
clinical specialists in 30 cases, by general practitioners in
17 cases, and by both in 55 cases. Relatives who had been
closely involved with the patient could be contacted in 91
cases; 63 gave their written consent to be personally
interviewed at their own home. The reason for not
participating was most often that relatives expected partic-
ipation to be too burdensome. The patients for whom
bereaved relatives participated in an interview had on
average a longer disease duration (33 vs 21 months;
p=0.03) and were more often women (59 vs 28%;
p=0.004) than other patients.
The Medical Ethical Committee of the Erasmus MC,
University Medical Center Rotterdam approved the re-
search protocol.
Questionnaire for attending physicians
As soon as we were informed of the death of a patient,
physicians received a self-developed written questionnaire
addressing the end-of-life medical treatment and decision-
making. The median time between the patient’s death and
filling out the questionnaire was 12.5 weeks (range, 1 to
59 weeks). The questions on end-of-life decision-making
were based upon questionnaires that have proven to yield
valid information in previous studies [2, 13]. In cases
where both a clinical specialist and a general practitioner
filled out a questionnaire, the information about the patients’
anti-tumor treatment history, medical decision-making, and
any ‘negative’ aspects of the dying process were considered
to be additive.
Interview with bereaved relatives
Interviewers were trained to carry out interviews with
vulnerable people during a 2-day course. The interviews
were on average held 4.9 months after the patient’s death
(range, 0.8–9.5 months). The interview schedule included
the following topics: personal characteristics of the
bereaved relatives, such as age, sex, and relationship with
the patient; symptoms of the patient, that is, loss of
appetite, pain, fatigue, dyspnoea, nausea, mouth or
mucous problems, incontinence, bedsores, confusion, anx-
iety, and depression; and whether or not the patient was
treated for these symptoms. The patient symptom list was
based upon the European Organization for Research and
Treatment of Cancer Quality of Life Questionnaire C30
[14, 15] and the Problems and Needs in Palliative Care
questionnaire [16, 17] and completed with psychological
symptoms. Further, contacts with health care professionals,
admission to hospital or other care institutions, the actual and
preferred place of death, and problems in end-of-life care
during the last 3 days of life were assessed using scales from
the Voices of Informal Carers-Evaluation of Services
(VOICES) questionnaire [18]. Finally, we asked the be-
reaved relatives about the burden of care giving. We adapted
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several questions from the Caregiver Reaction Assessment to
make them applicable for an after-death interview with
bereaved relatives [19].
Statistical analyses
We compared the characteristics of patients who died in an
institution with the characteristics of patients who died at
home. Student’s t tests and χ2 tests were used to assess the
statistical significance of differences between both groups.
All analyses were done using the Statistical Package for the
Social Sciences version 11.0.
Results
The characteristics of all 103 deceased patients and of 63
patients for whom an after-death interview with a bereaved
relative was available are presented in Table 1. The mean
age at death of all patients was 65 years; 48 patients (47%)
were women. The most common types of cancer were lung
cancer (48 patients) and breast cancer (19 patients). Of all
103 patients, 49 died within an institution: 35 patients died
at a hospital department, 6 patients died after having been
admitted to a department within a hospital, nursing home,
or home for the elderly that was specialized in care for
Table 1 Characteristics of patients and bereaved relatives
Characteristics All deceased patients
(N=103)
Deceased patients for whom a relative
was interviewed (N=63)
Patients
Age at death, in years [mean (SD)] 65 (11) 64 (11)
Sex [n/N (%)]
Female 48/103 (47) 37/63 (59)
Living arrangement [n/N (%)]
With partner 76/103 (74) 47/63 (75)
Education [n/N (%)]
Lowa 71/102 (70) 41/63 (65)
Religion [n/N (%)]
Religious 62/103 (60) 40/63 (63)
Urbanization [n/N (%)]
Living in urban areab 72/103 (70) 46/63 (73)
Primary tumor site [n/N (%)]
Lung 48/103 (47) 31/63 (49)
Breast 19/103 (18) 14/63 (22)
Other 36/103 (35) 18/63 (29)
History of anti-tumor treatment [n/N (%)]
Surgery 45/102 (44) 26/62 (42)
Chemotherapy/hormone therapy 84/101 (83) 51/61 (84)
Radiotherapy 54/101 (54) 36/61 (59)
Place of death
Institution [n/N (%)] 49/103 (48) 29/63 (46)
Hospital 35/49 24/29
End-of-life care unit 6/49 2/29
Hospice 4/49 3/29
Nursing home/home for the elderly 4/49 –
At home or in a home-like situation [n/N (%)] 54/103 (52) 34/63 (54)
At patient’s own home 52/54 32/34
Elsewhere 2/54 2/34
Bereaved relatives
Age at the time of dying of the patient, in years [mean (SD)] – 55 (15)
Sex [n/N (%)]
Female – 40/63 (63)
Relative was patient’s [n/N (%)]:
Spouse – 39/63 (62)
Son or daughter – 19/63 (30)
Other relationship – 5/63 (8)
a Low education: lower vocational, lower secondary general education, or primary school
b Living in an urban area: patients who were treated as an outpatient in a hospital inside the Rotterdam area
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dying patients, 4 patients died within a general department
of a nursing home or home for the elderly, and 4 patients
died in a hospice. The remaining 54 patients died at home
or in a home-like situation: 52 patients died in their own
homes, 1 patient died in the home of a son, and 1 patient
died during a holiday on a boat. The only significant
difference between patients dying in an institution and
patients dying at home concerned the percentage who had
lived with a partner, which was 63% for patients who died
in an institution and 83% for patients who died at home. All
other characteristics of patients and relatives that are listed
in Table 1 were similar in both groups. The characteristics
of the group of patients for whom a relative could be
interviewed were also similar to the characteristics of the
total group. The interviewed relative was the patient’s
spouse in 39 out of the 63 cases; in 19 cases, it was a son or
daughter, and in 5 cases, another relative. The majority of
relatives were women, and their mean age was 55 years.
Some aspects of medical care are shown in Table 2. In
both groups, physicians reported that about two thirds of
the patients had died peacefully. Patients who died in an
institution had less often (37%) been ready to die than
patients who died at home (71%). Agitation was a common
problem during the dying process. Most patients in both
settings had been unconscious before death. Physicians had
discussed a number of end-of-life decisions each with about
one third of their patients: This holds for decisions to forgo
potentially life-prolonging treatment, intensive treatment of
pain, and active euthanasia. Sedation was the only
treatment option that was discussed slightly more often
with patients who died in an institution. Life had actually
been shortened due to the forgoing of potentially life-
prolonging treatment or to the use of potentially life-
shortening drugs in about one third of all cases in both
settings. Such medical decisions were usually made with
clear consent of the patient, and life was generally
shortened by less than 1 week.
Bereaved relatives reported in 25 out of 63 cases that the
patient had preferred to die at home (Table 3). Two patients
had preferred to die in the hospital, 3 in a hospice, 2
elsewhere, and for 31 patients, the relative indicated that the
patient had no clear preference. Most patients who had a
preference died at the place they preferred, except for five
patients who preferred home but died in the hospital.
Patients who died in an institution had stayed there for on
average 7 days. The number of transfers during 3 months
before death was larger for patients who died in an
institution (mean 1.9) than for patients who died at home
Table 2 Dying in an institution or at home: the physician’s perspective
Place of death P value χ2 test
In institution (N=49) At home (N=54)
N (%)
Physician’s evaluation of dying processa
Patient died peacefully 28/41 (68) 29/42 (69) 0.94
Patient was able to say goodbye to relatives 26/40 (65) 33/44 (75) 0.32
Patient was ready to die 15/41 (37) 31/44 (71) 0.002
Patient died suddenly and unexpectedly 13/42 (31) 14/44 (32) 0.93
Patient’s dying was preceded by period of agitation 25/40 (63) 29/41 (71) 0.43
Patient’s dying was preceded by period of unconsciousness 30/39 (77) 26/42 (62) 0.14
Physician discussed with patient medical decisions that could shorten
life
Forgoing treatment 13/49 (27) 15/50 (30) 0.70
Intensified pain treatment 16/49 (33) 16/50 (32) 0.95
Sedation 15/49 (31) 8/50 (16) 0.09
Euthanasia 18/49 (37) 19/50 (38) 0.90
Life was possibly shortened due to
Forgoing treatment 15/47 (32) 14/52 (27) 0.59
With clear consent of the patient 11/12 12/13
Life was shortened by more than 1 week 4/11 0/9
Use of potentially life-shortening drugs 16/46 (35) 13/45 (29) 0.55
With clear consent of the patient 12/14 9/10
With the explicit goal of shortening life 1/16 4/13
Life was shortened by more than 1 week 1/13 2/10
Information as provided by clinical specialist (n=85) and/or general practitioner (n=72). In case of conflicting answers concerning history of
treatment, the information as provided by the clinical specialist prevailed. In all other cases, both sources were considered valid.
a Statement was considered true if neither the clinical specialist nor the general practitioner considered it untrue.
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(mean 1.2), and the number of medical specialties that were
involved with the patient was also larger in institutions
(mean 2.2) than at home (mean 1.8). Care involved on
average six disciplines (medical and non-medical), both in
institutions and at home.
During the last 3 days of life, a large proportion of patients
in both settings suffered, according to the reports of bereaved
relatives, from fatigue, loss of appetite, pain, dyspnoea, and
mouth or mucus problems (Table 4). Patients dying in an
institution were somewhat more often incontinent and more
often suffered from anxiety. Patients dying at home slightly
more often had bedsores. There were no statistically
significant differences between the settings in the degree to
which symptoms were addressed with some form of medical
treatment, except for loss of appetite, for which 6 of 22
patients who died in an institution received treatment, but
only 2 of 30 patients who died at home (p=0.04). The
bereaved relatives’ evaluation of end-of-life care was in
general positive in both settings. Some relatives of patients
who died in an institution felt they had not sufficiently been
Table 3 Preferred and actual place of death
Preferred place of deatha Actual place of death Total (N=63)
In institution At home
Hospital
(N=24)
Hospice/end-of-life care unit
(N=5)
At patient’s own home
(N=32)
Elsewhere
(N=2)
Hospital 2 2
Hospice 3 3
At home 5 20 25
Other place 1 1 2
No (clear) preference 16 1 12 2 31
a Information as provided by bereaved relative
Table 4 Dying in an institution or at home: perspective of bereaved relative
Place of death P value t test P value χ2 test
In institution (N=29) At home (N=34)
Number of days patient stayed at place of death [mean (SD)] 7 (6) 59 (35) 0.000
Number of transfers [mean (SD)] 1.9 (1.7) 1.2 (1.3) 0.047
Number of disciplines involved with patient [mean (SD)] 6.1 (2.3) 5.8 (1.9) 0.64
Number of clinical specialties involved with patient [mean (SD)] 2.2 (1.2) 1.8 (0.8) 0.011
Patient [n (%)]
Was fatigued 22 (79) 29 (88) 0.33
Had loss of appetite 22 (76) 30 (88) 0.20
Had pain 20 (69) 29 (85) 0.12
Had dyspnoea 18 (62) 17 (52) 0.40
Had mouth or mucous problems 18 (62) 16 (49) 0.28
Was incontinent 20 (69) 13 (38) 0.015
Had nausea 9 (32) 10 (30) 0.88
Had bedsores 5 (17) 13 (38) 0.07
Was confused 14 (48) 10 (29) 0.12
Suffered from anxiety 12 (41) 5 (15) 0.021
Was depressed 3 (10) 2 (6) 0.54
Evaluation of care during the last 3 days of life [n (%)]
Assistance with personal care was sufficient 27 (93) 32 (94) 0.87
Nursing care was sufficienta 26 (90) 33 (97) 0.23
Relative was involved in decision-making 25 (89) 33 (97) 0.22
Relative was sufficiently involved in decision-making 24 (89) 33 (100) 0.049
Patient might have disagreed with medical decision(s) 4 (15) 1 (3) 0.10
Relative disagreed with medical decision(s) 7 (24) 7 (21) 0.78
It had been clear that patient was dying 18 (67) 26 (79) 0.29
a Including patients who did not need professional nursing care
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involved in the decision-making, whereas all relatives in the
other group were satisfied about their level of involvement.
Further, of the bereaved relatives who had cared for a
patient who died in an institution, 76% reported that it had
significantly affected their own social life; this percentage was
94% for relatives who had cared for a patient who died at
home (Table 5). A substantial number of relatives had only
received some or no support from other family members
(38%), and the number of relatives who reported that their
own health had been affected by caring for the patient was
also quite large (38%). Caring for a dying relative rarely
yielded financial problems. Nearly all relatives thought it
very important that they had been involved in caring for the
patient.
Discussion
Medical care for patients who are in the last stage of life has
received much attention during the past decade in The
Netherlands. The organization of health care services for
terminally ill patients has greatly expanded during a 5-year
period from 1998 through 2003, during which the govern-
ment financially supported six university-based centers for
the further development of end-of-life care. After this
period, the government took the position that, whereas
death and dying are common events, the provision of end-
of-life care should be part of the professional skills of all
physicians, including general practitioners providing end-
of-life care to patients who are staying at home. For
complex problems, general practitioners and other physi-
cians can now, in many places, seek support from expert
teams [20–22].
Of the 103 patients in this study, who were, at inclusion, all
treated as outpatients by a clinical specialist, about half died in
their own home. Death in an institution mostly concerned a
hospital, which was probably not, for all patients, foreseen as
the place of dying. Patient characteristics did not clearly
determine the place of dying in our study. Whether or not
patients lived with a partner was the only variable that was
significantly associated with the place of dying. Having
access to informal care support is invariably found to be a
strong determinant of being able to die at home [4]. Other
factors that have been found to affect rates of dying at home
are the health status and emotional capacity of the main
carer, the availability and use of home-based end-of-life care
services, the need for specialist symptom control, tumor
type, distance to inpatient services, gender and age of the
patient, the patient’s socio-economic status, and strength and
visibility of patient or carer preferences concerning the place
and circumstances of dying [4, 23–26]. Obviously, the
number of cases in our study was limited, and we did not
assess all possibly relevant factors, which precludes firm
conclusions on determinants of the place of dying. However,
Table 5 Dying in an institution or at home: experiences of bereaved relatives
Place of death P value χ2 test
In institution (N=29) At home (N=34)
n (%)
How often did you see patient in the last months of life? 0.78
Every day 24 (83) 29 (85)
Less than daily 5 (17) 5 (15)
Did caring for patient affect your own social life? 0.068
Yes 22 (76) 32 (94)
No 7 (24) 2 (6)
Did caring for patient result in financial problems? 0.17
Yes 4 (14) 1 (3)
No 25 (86) 33 (97)
Did you receive support from your family in caring for patient? 1.0
Much support 16 (55) 23 (68)
Some or no support 13 (45) 11 (32)
Did caring for patient affect your own health? 0.62
Yes 12 (41) 12 (35)
No 17 (59) 22 (65)
Did caring for patient cost you a lot of energy? 0.96
Often or all the time 15 (52) 15 (44)
Rarely or sometimes 14 (48) 19 (56)
How important was being involved with care for patient for you? 0.65
Very important 26 (90) 32 (94)
Important 3 (10) 2 (6)
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whereas access to the available public end-of-life care
services, both institutional and home-based, is virtually
unlimited in The Netherlands and financially covered by
either private or public insurance, care needs of patients are
probably a predominant factor.
The availability of in- and outpatient end-of-life care
services is probably another important determinant of place
of death. The number of patients who died in a specialized
end-of-life care service in our study was limited. National
statistics on the place of dying does not include hospices or
end-of-life care units as a separate category. However, the
percentage of cancer deaths inside such services as found in
our study is probably comparable to the percentage in the
total Dutch population. Recently, the number of beds in
specialized end-of-life care services in The Netherlands has
been rapidly increasing [27]. It is, therefore, likely that the
proportion of cancer deaths in end-of-life care services will
further increase in the coming years. However, the extent to
which dying in an end-of-life care service will substitute
dying in a hospital or dying at home is hard to predict.
Probably, institutional end-of-life care services address very
diverse needs of dying patients and their caregivers.
Further, financial and other incentives that are aimed at
setting the course for the supply of end-of-life care services
may affect developments concerning the place of dying and
end-of-life care as well [27].
It is remarkable that a substantial number of patients in
our study did not have a clear preference concerning their
place of dying. Obviously, we only have information about
the preferences that patients had discussed with their
interviewed relative. Patients may also have had wishes
that relatives were not aware of. Nevertheless, the data in
our study suggest that the place of dying is not a great
concern for a substantial number of terminally ill cancer
patients in The Netherlands.
In general, we found few differences in the evaluation by
physicians and bereaved relatives of the dying phase of
patients who died in an institution and patients who died at
home. Patients who died in an institution were, according to
their physicians, less often ready to die, which may be due
to the fact that hospitalization is typically forgone in
patients who are expected to die at short notice. A sudden
and more rapid deterioration than expected may also have
been among the reasons to admit patients to hospital shortly
before dying in some cases. We did not find substantial
differences between both settings in most end-of-life
decision-making characteristics. Relatives in both settings
quite often (21–24%) stated that they had not agreed with
the decision-making. Relatives of patients who died in an
institution somewhat less often than other relatives felt that
they had been sufficiently involved in the decision-making.
Dissatisfaction of relatives with end-of-life decision-making
in an institutional setting has been described elsewhere too
[28–30] and has been attributed to many factors, such as a
lack of time of professional caregivers, lack of skills in
communication, failure to recognize end-of-life decision-
making as a subject that could be discussed, ethical barriers,
and the lack of emotional support for relatives [28–32]. It is
unclear if our finding that relatives of patients who died
outside an institutional setting more often feel satisfied
about their involvement in the decision-making process is
due to better communication in the home situation.
However, the general practitioner, who often has a long-
standing relationship with patients and their families,
typically plays a key role in end-of-life care at home and
may be better able to adequately communicate with family
than institutional caregivers [33]. Medical decision-making
may also be less complex or controversial for patients who
die at home.
The possibly rather complex decision-making in institu-
tions is not associated with a higher prevalence of most
symptoms. Fatigue, pain, and dyspnoea were among the
most common symptoms in both settings, as has been
found elsewhere too [34]. Incontinence was more common
among patients dying in an institution, and this also holds
for anxiety, which was reported as a problem for almost
half of all patients dying in an institution. Incontinence and
mental status have elsewhere also been found to be
associated with a need of nursing home care [35]. In
contrast, bedsores were more common at home.
Virtually all relatives in both settings were satisfied
about the personal and nursing care that had been provided
to their dying relative. This may, to some extent, be
indicative of the relative quality of end-of-life care in
institutions and at home, but using satisfaction as an
absolute indicator of the quality of palliative care services
is quite problematic [36]. Further, most relatives were
closely involved and appreciated their personal involve-
ment very much, both for patients who died in an institution
and patients who died at home. Nevertheless, caring for a
dying relative often affected their own social life, especially
when dying occurred at home, and took a lot of energy.
Our study has several limitations. Firstly, the patients’
perspectives on their own dying process is lacking.
Bereaved family members’ assessments are known to
sometimes disagree with those of the patients’, especially
for subjective aspects such as psychological symptoms and
pain [37]. This is also true for physicians’ assessment of
their patients’ condition. Secondly, our group of patients is
probably not representative for all patients dying from one
of the five major types of cancer because patients with a
very poor health status and patients who died shortly after
the diagnosis of incurable cancer were not included in the
cohort study upon which the data collection for this study
was based. Moreover, data from bereaved relatives could
only be obtained for 61% of all patients, which may have
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resulted in an overestimation of the degree of satisfaction of
relatives. The fact that patients of whom no bereaved
relative participated in the study had a shorter disease
duration at inclusion than other patients suggests that a
rapidly progressive disease process makes it more difficult
for bereaved relatives to talk about the last phase of life of
the patient.
In summary, we did not find major differences in the
process and quality of dying between institutional settings
and the home setting. Most patients with clear preferences
concerning their place of dying were able to die at their
preferred place. In about half of all cases, relatives were not
aware of any preference of the patient concerning the place
of dying, which is apparently not a major concern for many
people. We conclude that the current situation in The
Netherlands, in which the place of dying is mainly
determined by the availability of informal caregivers at
home and the care needs of the patient, involves no major
threats to the process and quality of dying.
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